Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
29.17
+0.16 (0.55%)
At close: May 26, 2026, 4:00 PM EDT
29.10
-0.07 (-0.24%)
After-hours: May 26, 2026, 6:44 PM EDT
Rigel Pharmaceuticals Market Cap
Rigel Pharmaceuticals has a market cap or net worth of $539.71 million as of May 26, 2026. Its market cap has increased by 59.77% in one year.
Market Cap
539.71M
Enterprise Value
438.74M
1-Year Change
59.77%
Ranking
Category
Stock Price
$29.17
Market Cap Chart
Since November 29, 2000, Rigel Pharmaceuticals's market cap has increased from $254.90M to $539.71M, an increase of 111.73%. That is a compound annual growth rate of 2.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 536.70M | -30.96% |
| Dec 31, 2025 | 777.40M | 162.37% |
| Dec 31, 2024 | 296.30M | 17.21% |
| Dec 29, 2023 | 252.80M | -2.51% |
| Dec 30, 2022 | 259.30M | -42.78% |
| Dec 31, 2021 | 453.20M | -23.37% |
| Dec 31, 2020 | 591.40M | 64.87% |
| Dec 31, 2019 | 358.70M | -6.42% |
| Dec 31, 2018 | 383.30M | -32.57% |
| Dec 29, 2017 | 568.40M | 141.36% |
| Dec 30, 2016 | 235.50M | -12.19% |
| Dec 31, 2015 | 268.20M | 34.57% |
| Dec 31, 2014 | 199.30M | -20.02% |
| Dec 31, 2013 | 249.20M | -55.93% |
| Dec 31, 2012 | 565.50M | 0.60% |
| Dec 30, 2011 | 562.10M | 43.14% |
| Dec 31, 2010 | 392.70M | -20.31% |
| Dec 31, 2009 | 492.80M | 68.36% |
| Dec 31, 2008 | 292.70M | -62.86% |
| Dec 31, 2007 | 788.20M | 164.67% |
| Dec 29, 2006 | 297.80M | 47.43% |
| Dec 30, 2005 | 202.00M | -57.71% |
| Dec 31, 2004 | 477.70M | 68.26% |
| Dec 31, 2003 | 283.90M | 465.54% |
| Dec 31, 2002 | 50.20M | -71.28% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tectonic Therapeutic | 549.47M |
| Ginkgo Bioworks Holdings | 549.38M |
| Assembly Biosciences | 545.58M |
| Valneva SE | 544.46M |
| MiMedx Group | 539.18M |
| Prime Medicine | 536.43M |
| ProKidney | 528.60M |
| Forte Biosciences | 527.57M |